DYN DYNE THERAPEUTICS
Health Care · Russell 2000
Next earnings: not announced yet
What 20 analyst firms say about DYNE THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
19 rated views · 21 analyst/firm records · 20 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8054
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8045
Recent analyst activity · last 90 days
Our tracked history has 16 reports on DYN from 14 analyst firms in the last 90 days (21 firms in the past year).
Comparing each firm's latest target with its previous one: 5 lowered it, 4 left it unchanged and 3 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 2 downgrades.
Latest observed target change: Oppenheimer lowered its target from $40.00 (set 10 Dec 2025) to $15.00 on 28 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Brian Skorney | Buy | 9 Sep 2026 | 26.00 USD |
| Bernstein | William Pickering | Hold | 13 May 2026 | 24.00 USD |
| Cantor Fitzgerald | Eric Schmidt | Buy | 30 Sep 2026 | — |
| Chardan Capital Markets | Keay Nakae | Buy | 30 Sep 2026 | 38.00 USD |
| Evercore ISI | Gavin Clark-Gartner | Buy | 13 Sep 2026 | 28.00 USD |
| Guggenheim | Debjit Chattopadhyay | Buy | 1 Jul 2026 | 50.00 USD |
| H.C. Wainwright | Ananda Ghosh | Buy | 30 Sep 2026 | 32.00 USD |
| Jefferies | Andrew Tsai | Buy | 30 Sep 2026 | 50.00 USD |
| Jonestrading | Catherine Novack | Buy | 9 Mar 2026 | 35.00 USD |
| JPMorgan | Tessa Romero | Sell | 9 Sep 2026 | 10.00 USD |
| Lifesci Capital | Francois Brisebois | Buy | 11 May 2026 | 44.00 USD |
| Morgan Stanley | Michael Ulz | Buy | 9 Sep 2026 | 36.00 USD |
| Oppenheimer | Andreas Argyrides | Buy | 10 Dec 2025 | 40.00 USD |
| Oppenheimer | Kostas Biliouris | Hold | 28 Oct 2026 | 15.00 USD |
| Piper Sandler | Edward Tenthoff | Buy | 29 Sep 2026 | 47.00 USD |
| Raymond James | Martin Auster | Buy | 29 Jul 2026 | 37.00 USD |
| RBC Capital Markets | Luca Issi | Buy | 9 Sep 2026 | 30.00 USD |
| Stifel | Paul Matteis | — | 30 Sep 2026 | 37.00 USD |
| TD Cowen | Joseph Thome | Buy | 26 Jun 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 26 May 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:51 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.